View on Amazon.com https://www.amazon.com/dp/B0BPRCZ1QF Audio y Texto NEW GENRE Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases – Series A, Volume 5 https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-five-pharmacological-agents-in-treatment-of-cardiovascular-diseases-series-a-volume-5/ Original Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases NEW GENRE Volume Five: Pharmacological Agents in Treatment of Cardiovascular Diseases https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-five-pharmacological-agents-in-treatment-of-cardiovascular-diseases-series-a-volume-5/ This volume has the following three parts: PART A: […]
Search Results for 'HDL'
Agentes farmacológicos en el tratamiento de las enfermedades cardiovasculares
Posted in on June 7, 2022|
Injectable inclisiran (siRNA) as 3rd anti-PCSK9 behind mAbs Repatha and Praluent
Posted in Atherogenic Processes & Pathology, Drug Delivery Platform Technology, Exosomes: Natural Carriers for siRNA Delivery, FDA Regulatory Affairs, Frontiers in Cardiology and Cardiovascular Disorders, Gene Therapy & Gene Editing Development, Genome Biology, Genomics Pharmacy, Origins of Cardiovascular Disease, Pharmacotherapy of Cardiovascular Disease on November 18, 2019| Leave a Comment »
Injectable inclisiran (siRNA) as 3rd anti-PCSK9 behind mAbs Repatha and Praluent Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 4/27/2021 Combining AstraZeneca’s ‘good’ cholesterol booster with PCSK9 inhibition shows promise in heart disease by Angus Liu | Apr 21, 2021 3:00pm The drug, dubbed MEDI5884, is designed to neutralize a circulating enzyme called endothelial lipase. The protein regulates […]
Volume Eight: 2nd Edition of Volume Two: Title of Volume Eight: Text Mining with Machine Learning, Book Glossary from Article’s WordClouds. Title of Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation
Posted in on February 17, 2024| Leave a Comment »
Series A: e-Books on Cardiovascular Diseases Series A Content Consultant: Justin D Pearlman, MD, PhD, FACC Volume Eight is 2nd Edition of Volume Two Title of Volume Eight: Text Mining with Machine Learning, Book Glossary from Article’s WordClouds. Title of Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation […]
Investigación original cardiovascular: casos de diseño de metodología para la selección de contenidos El arte de la selección de contenidos científicos y médicos
Posted in on June 6, 2022|
View on Amazon.com https://www.amazon.com/dp/B0BPRBVLD3 Audio y Texto NEW GENRE Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation: Series A, Volume 2 https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-two-cardiovascular-original-research-cases-in-methodology-design-for-content-co-curation-series-a-volume-2/ Original Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation NEW GENRE Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation […]
NEW GENRE Volume One: Metabolic Genomics & Pharmaceutics – Series D, Volume 1
Posted in on July 6, 2022|
View on Amazon.com http://www.amazon.com/dp/B0BR8DPPZW Audio y Texto NEW GENRE Volume One: Metabolic Genomics & Pharmaceutics https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-d-e-books-on-biomedicine-metabolomics-immunology-infectious-diseases-reproductive-genomic-endocrinology/new-genre-volume-one-metabolic-genomics-pharmaceutics-series-d-volume-1%ef%bf%bc/ Original Volume One: Metabolic Genomics & Pharmaceutics VOLUME 1: Metabolic Genomics and Pharmaceutics. On Amazon.com since 7/21/2015 http://www.amazon.com/dp/B012BB0ZF0 NEW GENRE Volume One: Metabolic Genomics & Pharmaceutics – Series D, Volume 1 https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-d-e-books-on-biomedicine-metabolomics-immunology-infectious-diseases-reproductive-genomic-endocrinology/new-genre-volume-one-metabolic-genomics-pharmaceutics-series-d-volume-1%ef%bf%bc/ This volume has the following three parts: PART A: The […]
Etiología de las enfermedades cardiovasculares: epigenética, genética y genómica
Posted in on June 7, 2022|
View on Amazon.com https://www.amazon.com/dp/B0BPR8ZCT3 Audio y Texto NEW GENRE Volume Three: Etiologies of Cardiovascular Diseases – Epigenetics, Genetics and Genomics – Series A, Volume 3 https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-three-etiologies-of-cardiovascular-diseases-epigenetics-genetics-and-genomics-series-a-volume-3/ Original Volume Three: Etiologies of Cardiovascular Diseases – Epigenetics, Genetics and Genomics NEW GENRE Volume Three: Etiologies of Cardiovascular Diseases – Epigenetics, Genetics and Genomics https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-a-e-books-on-cardiovascular-diseases/new-genre-volume-three-etiologies-of-cardiovascular-diseases-epigenetics-genetics-and-genomics-series-a-volume-3/ This volume has […]
Paraoxonase 2 (PON2) appears to play a cardioprotective role in both human and experimental heart failure: Cardiologist Wai Hong Wilson Tang, MD, Director of Cleveland Clinic Lerner Research Institute’s Center for Clinical Genomics.
Posted in Frontiers in Cardiology and Cardiovascular Disorders, Heart Failure (HF), inflammation independent of lipid levels, tagged Paraoxonase 2 (PON2) on January 1, 2019| Leave a Comment »
Paraoxonase 2 (PON2) appears to play a cardioprotective role in both human and experimental heart failure: Cardiologist Wai Hong Wilson Tang, MD, Director of Cleveland Clinic Lerner Research Institute’s Center for Clinical Genomics. Reporter: Aviva Lev-Ari, PhD, RN Enzyme Protects Heart Against Stress and Could Potentially Lead to New Heart Failure Treatments https://consultqd.clevelandclinic.org/enzyme-protects-heart-against-stress-and-could-potentially-lead-to-new-heart-failure-treatments/amp/?__twitter_impression=true Categories: Basic Research, Heart & Vascular, Research […]
Noam Steiner Tomer, Summer Internship, Research Assistant 1
Posted in on June 17, 2020|
Noam Steiner Tomer, Summer Internship, Research Assistant 1 8/11/2020 Aviva Lev-Ari, PhdD, RN, Founder & DIrector Leaders in Pharmaceutical Business Intelligence (LPBI) Group 83 Mandalay Road Newton, MA 02459 To Whom It May Concern: It is my pleasure to write this letter of recommendation for Noam Steiner Tomer. Noam worked for […]